Researchers Identify Possible Immune Targets in SARS-CoV-2 GenomeJuly 22, 2020
Researchers from the University of Otago in New Zealand have discovered potential target points on the SARS-CoV-2 genome, which may contribute to future treatments for the virus.
The researchers used their skills in microRNA (miRNA) from their usual study of anti-cancer CAR T cells, to examine previously unrecognized weak points on the SARS-CoV-2 genome that could be used to destroy the virus or help create new vaccines. These weak points are target sites recognized by host miRNA – a nucleic acid-based 'immune system' operating in all of our body's cells.
One target site on SARS-CoV-2 matches an abundant miRNA (miR197) present at very high levels in patients with cardiovascular complications or with respiratory viral infections. The miR197 binding site on SARS-2 had been independently mutated nearly 40 times since March this year. This mutation is now present in more than 75 percent of SARS-CoV-2 global isolates. The researchers, however, say that it's still early to say if such mutations will help the virus, or are simply neutral hitchhikers that confer no advantage to the virus.
For more details, read the news article in the University of Otago website.
You might also like:
- MIT-Engineered Peptide Targets COVID-19
- Scientists Find Potential Targets for COVID-19 Vaccine
- Pocket K No. 58: COVID-19 Treatment Efforts Using Plant Technologies
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- GM Crops' Impact Creates a Halo Effect, Expert Explains
- ISAAA Launches Open-access Resources on Genome Editing
- Oat Genome Now on ARS Website
- Most Accurate Map of Pig Genome Gives Insights to Breeding Healthier Animals
- Researchers Develop Fine-tune Methods for Gene Silencing
- Scientists Use CRISPR-Cas9 for Single-nucleotide Editing in Rice
- TALENs Used to Edit Mitochondrial DNA
- Experts Review Methods Used to Minimize Off-Target Effects in Genome Editing
- Researchers Turn to CRISPR Genome Editing to Make Cyanide-Free Cassava
- Structural Analysis of COVID-19 Spike Protein Describes its Evolution
- Researchers Identify Possible Immune Targets in SARS-CoV-2 Genome
- Human Trials Begin for COVID-19 Plant-Based Technology Vaccine
Read the latest:
- Biotech Updates (June 7, 2023)
- Gene Editing Supplement (May 31, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: